Literature DB >> 19019087

Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70.

Malabendu Jana1, Kalipada Pahan.   

Abstract

Interleukin-12 (IL-12) p70 (p40:p35) is a bioactive cytokine and its biological functions are becoming clear. On the other hand, the IL-12 p40 homodimer (p40(2)) was considered an inactive or inhibitory molecule and its functions are poorly understood. It has been reported that increased expression of lymphotoxin-alpha (Lt-alpha) in the central nervous system as well as in peripheral immune cells is associated with multiple sclerosis and experimental allergic encephalomyelitis. Here we describe that p40(2) induces the expression of Lt-alpha in primary mouse and human microglia, BV-2 microglial cells, splenic macrophages, RAW 264.7 cells and splenic T cells. Interestingly, IL-12 p70 was either unable to induce Lt-alpha or was a very weak inducer of Lt-alpha in these cell types. Consistently, p40(2), but not p70, induced Lt-alpha promoter-driven luciferase activity in microglial cells. Among various stimuli tested, p40(2) emerged as the most potent followed by IL-16, lipopolyaccharide and double-stranded RNA in inducing the activation of Lt-alpha promoter in microglial cells. Furthermore, an increase in Lt-alpha messenger RNA expression by overexpression of p40, but not p35, complementary DNA and induction of Lt-alpha expression by p40(2) in microglia isolated from IL-12p35(-/-) mice confirm that p40, but not p35, is responsible for the induction of Lt-alpha. Finally, by using primary microglia from IUL-12 receptor beta1 deficient (IL-12Rbeta1(-/-)) and IL-12Rbeta2(-/-) mice, we demonstrate that p40(2) induced the expression of Lt-alpha in microglia and macrophages via IL-12Rbeta1, but not IL-12Rbeta2. These studies delineate a novel biological function of p40(2) that is absent in IL-12.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019087      PMCID: PMC2712100          DOI: 10.1111/j.1365-2567.2008.02985.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  58 in total

1.  CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells.

Authors:  M M Worm; A Tsytsykova; R S Geha
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

Review 2.  The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.

Authors:  M K Gately; L M Renzetti; J Magram; A S Stern; L Adorini; U Gubler; D H Presky
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

3.  Antibodies to lymphotoxin alpha (LT alpha) and LT beta recognize different glial cell types in the central nervous system.

Authors:  B Cannella; I D Sizing; C D Benjamin; J L Browning; C S Raine
Journal:  J Neuroimmunol       Date:  1997-09       Impact factor: 3.478

4.  Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells.

Authors:  D Matusevicius; V Navikas; M Söderström; B G Xiao; M Haglund; S Fredrikson; H Link
Journal:  J Neuroimmunol       Date:  1996-05       Impact factor: 3.478

5.  Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis.

Authors:  J J Bright; B F Musuro; C Du; S Sriram
Journal:  J Neuroimmunol       Date:  1998-02       Impact factor: 3.478

6.  A lymphotoxin-beta-specific receptor.

Authors:  P D Crowe; T L VanArsdale; B N Walter; C F Ware; C Hession; B Ehrenfels; J L Browning; W S Din; R G Goodwin; C A Smith
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

7.  Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.

Authors:  V Navikas; B He; J Link; M Haglund; M Söderström; S Fredrikson; J Höjeberg; J Qiao; T Olsson; H Link
Journal:  Brain       Date:  1996-02       Impact factor: 13.501

8.  Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats.

Authors:  D Zipris; D L Greiner; S Malkani; B Whalen; J P Mordes; A A Rossini
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

9.  Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2007-03-08       Impact factor: 4.147

10.  A critical role for lymphotoxin in experimental allergic encephalomyelitis.

Authors:  W E Suen; C M Bergman; P Hjelmström; N H Ruddle
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

View more
  20 in total

1.  Intrathecal effects of daclizumab treatment of multiple sclerosis.

Authors:  B Bielekova; N Richert; M L Herman; J Ohayon; T A Waldmann; H McFarland; R Martin; G Blevins
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

Review 2.  Interleukin-23: as a drug target for autoimmune inflammatory diseases.

Authors:  Chunlei Tang; Shu Chen; Hai Qian; Wenlong Huang
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

Review 3.  Cytokine gene polymorphisms and human autoimmune disease in the era of genome-wide association studies.

Authors:  Koen Vandenbroeck
Journal:  J Interferon Cytokine Res       Date:  2011-12-22       Impact factor: 2.607

4.  Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.

Authors:  E Marks; C Naudin; G Nolan; B J Goggins; G Burns; S W Mateer; J K Latimore; K Minahan; M Plank; P S Foster; R Callister; M Veysey; M M Walker; N J Talley; G Radford-Smith; S Keely
Journal:  Mucosal Immunol       Date:  2017-01-25       Impact factor: 7.313

5.  Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor β.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  Neurochem Res       Date:  2012-04-17       Impact factor: 3.996

6.  Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis.

Authors:  Susanta Mondal; Avik Roy; Kalipada Pahan
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-γ.

Authors:  Madhuchhanda Kundu; Avik Roy; Kalipada Pahan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

8.  Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease.

Authors:  Azizul Haque; Supriti Samantaray; Varduhi H Knaryan; Mollie Capone; Azim Hossain; Denise Matzelle; Raghavendar Chandran; Donald C Shields; Ariana Q Farrand; Heather A Boger; Naren L Banik
Journal:  Exp Neurol       Date:  2020-04-14       Impact factor: 5.330

9.  IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAE.

Authors:  Susanta Mondal; Madhuchhanda Kundu; Malabendu Jana; Avik Roy; Suresh B Rangasamy; Khushbu K Modi; Jennillee Wallace; Yasmeen A Albalawi; Roumen Balabanov; Kalipada Pahan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-19       Impact factor: 11.205

10.  Interleukin-12 (IL-12), but not IL-23, induces the expression of IL-7 in microglia and macrophages: implications for multiple sclerosis.

Authors:  Malabendu Jana; Susanta Mondal; Arundhati Jana; Kalipada Pahan
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.